{
  "id": 11071,
  "rank": 214,
  "name": "ViprasolMACrossEA",
  "aka": [],
  "family": "A",
  "subtype": "A1",
  "one_liner": "EMA crossover with RSI/ADX filters, fixed-or-risk money management, break-even, trailing stops, daily trade cap, and on-chart dashboard",
  "market_regime": "any",
  "timeframes": [
    "any"
  ],
  "symbols": [
    "any"
  ],
  "sessions": [
    "any"
  ],
  "indicators": [
    {
      "name": "EMA",
      "params": {
        "period": 12
      },
      "applied_to": "close"
    },
    {
      "name": "EMA",
      "params": {
        "period": 26
      },
      "applied_to": "close"
    },
    {
      "name": "RSI",
      "params": {
        "period": 14
      },
      "applied_to": "close"
    },
    {
      "name": "ADX",
      "params": {
        "period": 14
      },
      "applied_to": "close"
    }
  ],
  "entry_long": [
    "EMA crossover (fast > slow)"
  ],
  "entry_short": [
    "EMA crossover (fast < slow)"
  ],
  "exit_rules": [
    "Close on opposite EMA cross",
    "Break-even when in profit",
    "Trailing stop in ATR, points, or off mode"
  ],
  "filters": [
    "RSI filter (skip overbought longs/oversold shorts)",
    "ADX filter (require trend strength)",
    "Time filter (server-time window)",
    "Spread filter (skip wide spreads)"
  ],
  "stop_loss": "ATR multiple",
  "take_profit": "ATR multiple",
  "position_size": "Fixed lot size or risk percent of equity",
  "evidence_type": "source_code",
  "completeness": 80.0,
  "signal_warnings": null,
  "claim_warnings": null,
  "opacity_warnings": null,
  "build_warnings": [
    "MT4_ONLY: the captured source is MQL4 / written for MetaTrader 4. It needs porting (order functions, indicator handles) before it runs on MT5."
  ],
  "canonical": "https://prismaticalgos.com/compendium/algo/11071-viprasolmacrossea",
  "snapshot": "2026-10-31 15:46 UTC",
  "source_url": "https://github.com/Viprasol-Tech/mt4-expert-advisor",
  "limitations": "These are machine-extracted research records, not verified trading systems. Catalog rank measures specification detail and claimed evidence, not profitability. The catalog extraction pipeline did not independently backtest these records. Its separate selected testing ledger does not validate the wider corpus. Rules, labels and parameters can be incomplete or wrong; consult the original source and its reuse terms."
}